Amarantus BioScience Holdings, Inc.
AMBS
$0.0001
$0.000.00%
OTC PK
| 06/30/2019 | 03/31/2019 | 06/30/2018 | |||
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | ||
| Total Other Revenue | -- | -- | -- | ||
| Total Revenue | -- | -- | -- | ||
| Cost of Revenue | -- | -- | -- | ||
| Gross Profit | -- | -- | -- | ||
| SG&A Expenses | 436.70K | 436.70K | 1.26M | ||
| Depreciation & Amortization | -- | -- | -- | ||
| Other Operating Expenses | -- | -- | -- | ||
| Total Operating Expenses | 437.00K | 437.00K | 1.27M | ||
| Operating Income | -437.00K | -437.00K | -1.27M | ||
| Income Before Tax | -412.00K | -412.00K | -1.74M | ||
| Income Tax Expenses | -- | -- | -- | ||
| Earnings from Continuing Operations | -412.00K | -412.00K | -1.74M | ||
| Earnings from Discontinued Operations | -- | -- | -- | ||
| Extraordinary Item & Accounting Change | -- | -- | -- | ||
| Minority Interest in Earnings | -- | -- | -- | ||
| Net Income | -412.00K | -412.00K | -1.74M | ||
| EBIT | -437.00K | -437.00K | -1.27M | ||
| EBITDA | -- | -- | -- | ||
| EPS Basic | 0.00 | 0.00 | -- | ||
| Normalized Basic EPS | 0.00 | 0.00 | -- | ||
| EPS Diluted | 0.00 | 0.00 | -- | ||
| Normalized Diluted EPS | 0.00 | 0.00 | -- | ||
| Average Basic Shares Outstanding | 252.50M | 252.50M | -- | ||
| Average Diluted Shares Outstanding | 252.50M | 252.50M | -- | ||
| Dividend Per Share | -- | -- | -- | ||
| Payout Ratio | -- | -- | -- | ||